natgillin/translations-raw huggingface dataset:
There have been isolated reports of non-serious allergic reactions to GONAL-f.
Obstajajo posamična poročila o neogrožajočih alergijskih reakcijah na GONAL- f.
If you had this type of reaction to similar medicines, inform your doctor.
Če ste že imeli to vrsto reakcije na podobna zdravila, prosimo, da o tem obvestite svojega zdravnika.
If you are a man, elevated follicle stimulating hormone blood levels are indicative of testicular damage.
Če ste moški, povišana raven folikle stimulirajočega hormona v krvi kaže na poškodbo testisov.
GONAL-f is usually not effective in such cases.
V takih primerih GONAL- f običajno ni učinkovit.
To monitor the treatment, your doctor may ask you for a semen analysis to be performed 4 to 6 months after the beginning of treatment.
Za spremljanje vašega zdravljenja, vas bo lahko vaš zdravnik napotil na semensko analizo 4 do 6 mesecev po začetku zdravljenja.
162 GONAL-f should not be administered as a mixture with other medicinal products in the same injection, except for lutropin alfa.
GONALA- f se ne sme dajati v obliki mešanice z drugimi zdravili v isti injekcijski brizgi, razen z lutropinom alfa.
Studies have shown that these two medicines can be mixed and injected together, without either product being adversely affected.
Študije so pokazale, da se ti dve zdravili lahko meša in skupaj injicira, ne da bi to
GONAL-f is not indicated if you are pregnant or are breast-feeding.
GONAL- f ni indiciran, če ste noseči ali če dojite.
Important information about some of the ingredients of GONAL-f
Pomembne informacije o nekaterih sestavinah zdravila GONAL- f
GONAL-f contains less than 1 mmol sodium (23 mg) per dose, i. e. essentially “ sodium-free”.
GONAL- f vsebuje manj kot 1 mmol natrija (23 mg) na odmerek, kar pomeni, da je v bistvu brez natrija.
HOW TO USE GONAL-f
KAKO UPORABLJATI GONAL- f
Always take GONAL-f exactly as your doctor has told you.
Pri uporabi zdravila GONAL- f natančno upoštevajte zdravnikova navodila.
Women who are not ovulating and are having irregular periods or no periods at all.
Ženske, ki nimajo ovulacije in imajo neredne menstruacije ali menstruacij sploh nimajo
GONAL-f is usually given every day.
GONAL- f se običajno daje vsak dan.
If you have periods, the treatment should start within the first 7 days of the menstrual cycle.
Če imate menstruacije, se mora zdravljenje začeti v prvih 7 dneh menstrualnega cikla.
A commonly used dose starts at 75-150 IU FSH every day.
FSH vsak dan.
This may be increased by 37.5 IU-75 IU at 7 or preferably 14 day intervals if necessary, to obtain an adequate, but not excessive, response.
Če je potrebno, se lahko za doseganje zadostnega, a ne pretiranega odziva, odmerek poveča za 37, 5 i. e. – 75 i. e. na 7 dni ali še bolje na 14 dni.
The maximal daily dose is usually not higher than 225 IU FSH.
Maksimalni dnevni odmerek običajno ni večji od 225 i. e.
If your doctor cannot see a response after 4 weeks of treatment, that treatment cycle should be abandoned.
Če vaš zdravnik ne more opaziti odziva po 4 tednih zdravljenja, je treba ta ciklus zdravljenja opustiti.
For the following cycle, your doctor will prescribe a treatment at a higher starting dose than in the abandoned cycle.
Za naslednji ciklus vam bo vaš zdravnik predpisal zdravljenje z večjim začetnim odmerkom kot v opuščenem ciklusu.
When an optimal response is obtained, a single injection of another medicine (hCG) is administered 24-48 hours after the last GONAL-f injection.
Ko je dosežen optimalni odziv, se v 24 - 48 urah po zadnji injekciji GONALA- f da ena sama injekcija drugega zdravila (hCG- ja).
You are recommended to have sexual intercourse on the day of the administration of this second medicine and the following day.
Priporočljivo je, da imate spolni odnos na dan, ko ste prejeli injekcijo drugega zdravila in naslednji dan.
If an excessive response is obtained, treatment should be stopped and hCG withheld (see Section 4).
Če pride do pretiranega odziva, je treba zdravljenje prekiniti in opustiti uporabo hCG (glejte poglavje 4).
For the following cycle, your doctor will prescribe a dosage lower than that of the previous cycle.
Za naslednji ciklus vam bo vaš zdravnik predpisal manjši odmerek od tistega v predhodem ciklusu.
Women undergoing ovarian stimulation for multiple follicular development prior to in vitro fertilisation or other assisted reproductive technologies.
Ženske v postopku stimulacije jajčnikov za doseganje razvoja več foliklov pred In vitro oploditvijo ali drugimi tehnikami asistirane reprodukcije:
A commonly used dose for superovulation involves the administration of 150-225 IU of GONAL-f daily, commencing on days 2 or 3 of the treatment cycle.
GONALA - f na dan, s pričetkom na 2. ali 3. dan ciklusa zdravljenja.
Treatment is continued until adequate follicular development has been achieved (as assessed by blood monitoring and/ or ultrasound examination), with the dose adjusted according to your response, to usually not higher than 450 IU daily.
Zdravljenje se nadaljuje, dokler ni dosežen zadovoljiv razvoj foliklov (kar se oceni s kontrolo krvi in/ ali z ultrazvočnim pregledom) z odmerkom, ki je prilagojen vašemu odzivu in običajno ni višji od 450 i. e. na dan.
Adequate follicular development is usually achieved on average by the tenth day of treatment (range 5 to 20 days).
Zadosten folikularni razvoj je v povprečju dosežen do desetega dneva zdravljenja (razpon 5 do 20 dni).
Then a single injection of a medicine used to induce final follicular maturation and containing up to 10 000 IU human chorionic gonadotrophin (hCG) is administered 24-48 hours after the last GONAL-f injection.
Nato se v 24- 48 urah po zadnji injekciji GONALA- f injicira ena sama injekcija zdravila za sprožitev končnega zorenja foliklov, ki vsebuje do 10 000 i. e. humanega horionskega gonadotropina (hCG- ja).
In other cases, down-regulation with a gonadotrophin-releasing hormone (GnRH) agonist is used.
V drugih primerih se uporabi negativna povratna regulacija z agonistom gonadotropin sproščajočega hormona (GnRH).
In these cases, GONAL-f is started approximately 2 weeks after the start of agonist treatment, both being continued until adequate follicular development is achieved.
V teh primerih pričnemo z dajanjem GONALA- f približno 2 tedna po začetku zdravljenja z agonistom in nadaljujemo z dajanjem obeh zdravil, dokler ni dosežen zadovoljiv razvoj foliklov.
The dose is then adjusted according to the ovarian response.
Odmerek se nato prilagodi glede na odziv jajčnikov.
163 Women who are not ovulating, having no periods at all and have been diagnosed as FSH and LH deficient.
Ženske, ki nimajo ovulacije, sploh nimajo menstruacij in imajo ugotovljeno pomanjkanje FSH- ja in LH- ja.
Your doctor will decide on the dose and schedule of administration which are most appropriate for you during this course of treatment.
Vaš zdravnik se bo odločil za odmerek in shemo dajanja, ki sta v poteku tega zdravljenja za vas
GONAL-f is usually taken every day for up to three weeks simultaneously with injections of lutropin alfa.
GONAL- f se običajno daje vsak dan do tri tedne, istočasno z injekcijami lutropina alfa.
A commonly used dose starts with 75-150 IU of GONAL-f together with 75 IU of lutropin alfa.
GONALA- f, skupaj s 75 i. e. lutropina alfa.
According to your response, your doctor may increase your dose of GONAL-f by preferably 37.5-75 IU at 7 to 14-day intervals.
Glede na vaš odziv, lahko zdravnik poveča vaš odmerek GONALA- f, po možnosti za 37, 5 – 75 i. e. v 7 do 14 dnevnih razmakih.
If your doctor does not observe a response of your ovaries after 3 weeks of treatment, that cycle should be abandoned.
Če vaš zdravnik ne opazi odziva vaših jajčnikov po 3 tednih zdravljenja, se mora ta ciklus opustiti.
For the following cycle, your doctor may prescribe treatment at a higher starting dose of GONAL-f than in the abandoned cycle.
Za naslednji ciklus pa vam vaš zdravnik lahko predpiše zdravljenje z večjim začetnim odmerkom GONALA- f kot v opuščenem ciklusu.
When the desired response has been obtained, a single injection of hCG is given 24-48 hours after the last injections of GONAL-f and lutropin alfa.
Ko je dosežen želeni odziv, se v 24 - 48 urah po zadnji injekciji GONALA- f in lutropina alfa injicira ena sama injekcija hCG- ja.
You are recommended to have sexual intercourse on the day of, and the day following, administration of the hCG.
Priporočljivo je, da imate spolni odnos na dan ko ste prejeli hCG in naslednji dan.
Alternatively, intrauterine insemination (IUI) may be performed.
Alternativno se lahko izvede intrauterina inseminacija (IUI).
If an excessive response is obtained, treatment should be stopped and hCG withheld (see section 4).
Če pride do pretiranega odziva, se mora zdravljenje prekiniti in opustiti dajanje hCG- ja (glejte poglavje 4).
For the following cycle, your doctor will prescribe GONAL-f at as lower dose than that of the previous cycle.
Za naslednji ciklus vam bo vaš zdravnik predpisal manjši odmerek GONALA- f kot je bil tisti v prejšnjem ciklusu.
Infertile men with hormonal deficiency.
Neplodni moški s hormonskim primanjkljajem.
GONAL-f is usually prescribed at a dose of 150 IU three times a week in combination with another medicine (hCG) for at least 4 months.
GONAL- f se običajno predpisuje v odmerku 150 i. e. trikrat na teden in v kombinaciji z drugim zdravilom (hCG) za najmanj 4 mesece.
If you have not responded to treatment after this period, your treatment may carry on for at least 18 months.
Če se po tem času niste odzvali na zdravljenje, se lahko z vašim zdravljenjem nadaljuje še najmanj 18 mesecev.
GONAL-f is intended for subcutaneous use, that means given by injection just under the skin.
GONAL- f je namenjen subkutani uporabi, kar pomeni, da se daje v obliki injekcije tik pod kožo.
If you administer GONAL-f to yourself, please carefully read the following instructions:
Če si sami dajete GONAL- f, natančno preberite naslednja navodila:
• Assemble and lay out on a clean surface everything you need:
Pomembno je, da so vaše roke in predmeti, ki jih uporabljate, čisti, kolikor je le mogoče. • Pripravite vse, kar potrebujete in položite na čisto površino:
one ampoule containing GONAL-f powder one solvent ampoule two alcohol swabs one syringe one needle for reconstitution and a fine bore needle for subcutaneous injection sharp container
eno ampulo z GONAL- f praškom eno ampulo z vehiklom dve alkoholni blazinici eno injekcijsko brizgo eno injekcijsko iglo za rekonstitucijo in eno fino injekcijsko iglo za subkutano injiciranje posodo za ostre predmete
• Open the ampoule of solvent (clear liquid):
• Odprite ampulo z vehiklom (bistra raztopina):
164 small coloured dot.
Na kapici ampule z vehiklom boste opazili majhno obarvano piko.
Directly below it is where the neck of the ampoule has been treated to make it easier to break.
Direktno pod njo je vrat ampule obdelan tako, da ga je najlažje zlomiti.
Gently flick the top section of the ampoule so that any fluid in the neck of the ampoule drops into the bottom chamber.
Nežno krcnite po vrhnjem delu ampule, tako da morebitna tekočina v vratu ampule odkaplja v spodnji prostor.
Carefully place the open ampoule upright on the work surface.
Odprto ampulo previdno položite v pokončnem položaju na delovno površino.
• Draw up the solvent:
• Izvlecite vehikel: pritrdite iglo za rekonstitucijo na injekcijsko brizgo, z injekcijsko brizgo v eni
Attach the needle for reconstitution to the syringe, with the syringe in one hand, pick up the open ampoule, insert the needle and draw up all of the solvent.
167 roki, primite odprto ampulo z drugo roko, ter vanjo vstavite iglo in izvlecite ven ves vehikel.
Carefully set the syringe down on the work surface, taking care not to touch the needle.
Napolnjeno injekcijsko brizgo previdno položite na delovno površino in pri tem pazite, da se ne dotaknete igle.
Open the ampoule containing the GONAL-f powder, pick up your syringe and slowly inject the solvent into the ampoule of powder.
• Odprite in pripravite raztopino za injiciranje: odprite ampulo, ki vsebuje prašek GONAL- f, vzemite vašo injekcijsko brizgo in počasi injicirajte vehikel v ampulo s praškom.
After the powder has dissolved (which usually occurs immediately), gently draw the solution back into the syringe.
Ko se prašek raztopi (kar se običajno zgodi takoj), previdno izvlecite raztopino nazaj v injekcijsko brizgo.
(If you have been prescribed more than one ampoule of GONAL-f, slowly re-inject the solution into another powder ampoule, until you have the prescribed number of powder ampoules dissolved in the solution.
(Če vam je zdravnik predpisal več kot eno ampulo GONALA- f, počasi ponovno injicirajte raztopino v drugo ampulo s praškom, dokler ne raztopite predpisanega števila ampul s praškom v raztopini.)
If you have been prescribed lutropin alfa in addition to GONAL-f, you may also mix the two medicines as an alternative to injecting each product separately.
Če vam je zdravnik predpisal lutropin alfa poleg GONALA- f, lahko zmešate obe zdravili, kar je alternativa injiciranju vsakega zdravila ločeno.
After dissolving the lutropin alfa powder, draw the solution back into the syringe and re-inject it into the ampoule containing GONAL-f.
Po raztapljanju praška lutropina alfa, izvlecite raztopino nazaj v injekcijsko brizgo in jo ponovno injicirajte v ampulo s praškom GONALA- f.
Inspect for particles as before, and do not use if the solution is not clear.
Ponovno preglejte raztopino na prisotnost delcev in če ni bistra, je ne smete uporabiti.
Up to three containers of powder may be dissolved in the content of one ampoule of solvent.)
Do tri vsebnike s praškom lahko raztopite v vsebini ene ampule z vehiklom.)
If you see air bubbles in the syringe, hold the syringe with the needle pointing upwards and gently flick the syringe until all the air collects at the top.
• Zamenjajte iglo s fino iglo za injiciranje in odstranite morebitne zračne mehurčke: če vidite mehurčke zraka v injekcijski brizgi, jo primite tako, da je igla usmerjena navzgor in nežno krcajte brizgo, da se ves zrak zbere na vrhu.
• Immediately inject the solution:
• Takoj injicirajte raztopino:
Your doctor or nurse will have already advised you where to inject (e. g. tummy, front of thigh).
Vaš zdravnik ali sestra sta vam že svetovala, kje dati injekcijo (n. pr. v trebuh, sprednjo stran stegna).
165 skin together and insert the needle at a 45° to 90° angle using a dart-like motion.
Trdno stistnite kožo skupaj in z gibom, podobnim metu sulice, zabodite iglo pod kotom 45° do 90°.
Immediately withdraw the needle and clean the skin with an alcohol swab using a circular motion.
Takoj izvlecite iglo in s krožnimi gibi očistite kožo z alkoholno blazinico.
• Dispose of all used items:
• Odstranite vse uporabljene predmete:
Once you have finished your injection, immediately discard all needles and empty ampoules in the sharp container provided.
Ko ste zaključili z injiciranjem, takoj zavrzite vse injekcijske igle in prazne ampule v priloženo posodo za ostre predmete.
If you use more GONAL-f than you should
Če ste uporabili večji odmerek zdravila GONAL- f kot bi smeli
The effects of an overdose of GONAL-f are unknown, nevertheless one could expect ovarian hyperstimulation syndrome to occur, which is further described in section 4.
Učinki prevelikega odmerka GONALA- f niso znani, vendar pa lahko pričakujemo pojav sindroma hiperstimulacije jajčnikov, ki je podrobno opisan v poglavju 4.
However this will only occur if hCG is administered (see section 2).
Vendar pa se to lahko pojavi samo, če se uporabi hCG (glejte poglavje 2).
If you forget to take GONAL-f
168 Če ste pozabili vzeti zdravilo GONAL- f
Do not take a double dose to make up for a forgotten dose, please contact your doctor.
Ne vzemite dvojnega odmerka, da bi nadomestili izpuščeni odmerek, temveč pokličite svojega zdravnika.
Like all medicines, GONAL-f can cause side effects, although not every body gets them.
Kot vsa zdravila ima lahko tudi zdravilo GONAL- f neželene učinke, ki pa se ne pojavijo pri vseh bolnikih.
Side effects in women The most commonly reported side effects are ovarian cysts, headache and local reactions at the injection site (pain, redness, bruising, swelling and/ or irritation).
Neželeni učinki pri ženskah Najbolj pogosti neželeni učinki, o katerih poročajo, so: ovarijske ciste, glavobol in lokalne reakcije na mestu injiciranja (bolečina, rdečina, modrica, oteklina in/ ali razdraženost kože).
Following treatment with GONAL-f when human chorionic gonadotrophin is administered, a condition called ovarian hyperstimulation syndrome (see section 2) can occur.
Po zdravljenju z GONALOM - f, ki mu sledi dajanje človeškega horionskega gonadotropina, se lahko pojavi stanje, ki se imenuje sindrom hiperstimulacije jajčnikov (glejte poglavje 2).
This syndrome is characterised by large ovarian cysts.
Za ta sindrom so značilne velike ovarijske ciste.
First symptoms of ovarian hyperstimulation are pain in the lower abdominal region, possibly in combination with nausea, vomiting and weight gain.
Prvi znaki hiperstimulacije jajčnikov so bolečina v spodnjem predelu trebuha, po možnosti v kombinaciji s slabostjo, bruhanjem in pridobivanjem telesne teže.
Should the above mentioned symptoms occur, a careful medical examination is indicated as soon as possible.
Če se pojavijo zgoraj našteti znaki, je potreben natančen zdravniški pregled, kakor hitro je mogoče.
In serious, but rare cases, an ovarian hyperstimulation syndrome with clearly enlarged ovaries, can go hand in hand with possible accumulation of fluid in the abdomen or thorax as well as more serious thromboembolic complications.
V hudih, vendar redkih primerih, se lahko sindromu hiperstimulacije jajčnikov z izrazito povečanimi jajčniki, pridruži še nabiranje tekočine v trebuhu ali prsnem košu, kakor tudi hujši tromboembolični zapleti.
In rare cases the latter can also be found independently of ovarian hyperstimulation syndrome.
V redkih primerih lahko slednje zasledimo neodvisno od sindroma hiperstimulacije jajčnikov.
In view of the above, to prevent such events, when the ovarian response is excessive, treatment with GONAL-f could be discontinued by your physician and the treatment with hCG abandoned.
Za preprečitev zgoraj naštetih zapletov pri pretiranem odzivu jajčnikov, lahko vaš zdravnik prekine zdravljenje z GONALOM- f in opusti zdravljenje s hCG- jem.
Rarely abnormal blood clottings (blood clots in blood vessels) have been seen to occur with similar medicines, so this could possibly occur with GONAL-f / hCG therapy or GONAL-f / lutropin alfa / hCG therapy.
Redko so pri podobnih zdravilih opazili pojav nenormalnih krvnih strdkov (krvni strdki v žilah), torej bi se to lahko pojavilo tudi pri zdravljenju z GONALOM- f / hCG- jem ali GONALOM- f / lutropinom alfa / hCG- jem.
These reactions can sometimes be serious.
V zelo redkih primerih so se na GONAL- f pojavile alergijske reakcije, ki so povzročile rdečico kože, izpuščaj, otekanje, koprivnico in težave z dihanjem. Te reakcije so včasih lahko resne.
Very rarely patients with asthma may experience worsening of their condition.
Pri bolnikih z astmo lahko zelo redko pride do poslabšanja stanja bolezni.
166 Ectopic pregnancy (embryo implanted outside the womb) may occur especially in women with a history of prior tubal disease.
Zunajmaternična nosečnost (zarodek vgnezden izven maternice) se lahko pojavi zlasti pri ženskah s predhodno boleznijo na jajcevodih.
Side effects in men Men may experience some breast development, acne or weight gain due to treatment with hCG.
Neželeni učinki pri moških Pri moških se lahko zaradi zdravljenja s hCG- jem pojavijo razvoj prsi, akne ali pridobivanje telesne mase.
Some men undergoing treatment with GONAL-f may experience local reactions at the injection site (pain, redness, bruising, swelling and/ or irritation) or may develop a varicocele (swelling of the veins above and behind the testicle).
Pri nekaterih moških, ki se zdravijo z zdravilom GONAL - f, se lahko pojavi lokalna reakcija na mestu injiciranja (bolečina, rdečina, modrica, oteklina in / ali razdraženost) ali se razvije varikokela (razširitev ven nad in za testisi).
HOW TO STORE GONAL-f
SHRANJEVANJE ZDRAVILA GONAL- f
Do not use GONAL-f after the expiry date which is stated on the ampoule after EXP.
169 poleg oznake EXP.
The medicine must be administered immediately after reconstitution.
Zdravilo morate injicirati takoj po rekonstituciji.
Do not use GONAL-f if you notice any visible signs of deterioration.
Ne uporabljajte zdravila GONAL- f, če opazite vidne znake kvarjenja.
What GONAL-f contains
Kaj vsebuje zdravilo GONAL- f
The active substance is follitropin alfa, 75 IU (International Units).
(mednarodnih enot).
Follitropin alfa is made from genetically engineered Chinese Hamster Ovary (CHO) cells.
Folitropin alfa je pridobljen iz genetsko spremenjenih celic jajčnika kitajskega hrčka (CHO – » Chinese Hamster Ovary «).
The other ingredients are sucrose, sodium dihydrogen phosphate monohydrate, disodium phosphate dihydrate, concentrated phosphoric acid and sodium hydroxide.
Pomožne snovi so: saharoza, natrijev dihidrogenfosfat monohidrat, natrijev hidrogenfosfatddihidrat, koncentrirana fosforjeva( V) kislina in natrijev hidroksid.
What GONAL-f looks like and contents of the pack
Izgled zdravila GONAL- f in vsebina pakiranja
GONAL-f is presented as a powder and solvent for solution for injection.
GONAL- f je v obliki praška in vehikla za raztopino za injiciranje.
The powder is a white lyophilised pellet.
Prašek je v obliki belih liofiliziranih pelet.
It is supplied in packs of 1, 5, 10 ampoules of powder with the corresponding number of solvent ampoules.
Na voljo je v škatlicah z 1, 5, 10 ampulami s praškom in ustreznim številom ampul z vehiklom.
167 One ampoule of powder contains 75 IU of follitropin alfa and one ampoule of solvent contains 1 ml of Water for Injections.
Ena ampula s praškom vsebuje 75 i. e. folitropina alfa in ena ampula z vehiklom vsebuje 1 ml vode za injekcije.
Merck Serono S. p. A., Via delle Magnolie 15, I-70026 Modugno (Bari), Italy.
Merck Serono S. p. A., Via delle Magnolie 15, I- 70026 Modugno (Bari), Italija
България MERCK d. o. o.
170 България MERCK d. o. o.
Ireland Merck Serono Ltd Bedfont Cross, Stanwell Road Feltham, Middlesex TW14 8NX United Kingdom Tel: +44-20 8818 7200
171 Ireland Merck Serono Ltd Bedfont Cross, Stanwell Road Feltham, Middlesex TW14 8NX United Kingdom Tel: +44- 20 8818 7200
INFORMATION FOR THE USER
172 NAVODILO ZA UPORABO
GONAL-f 150 IU powder and solvent for solution for injection Follitropin alfa
GONAL - f 150 i. e. prašek in vehikel za raztopino za injiciranje folitropin alfa
You and your partner's fertility should be evaluated before the treatment is started.
Pred pričetkom zdravljenja je potrebna ocenitev vaše plodnosti in plodnosti vašega partnerja.
171 Do not use GONAL-f
Ne uporabljajte zdravila GONAL- f
• if you are allergic (hypersensitive) to follicle stimulating hormone or any of the other ingredients of GONAL-f. • if you have tumours of the hypothalamus and pituitary gland
• če ste alergični na (preobčutljivi za) folikle stimulirajoči hormon ali katerokoli sestavino zdravila GONAL- f,
If you are a woman:
173 • če imate tumor hipotalamusa in hipofize
If you are a woman, this treatment increases your risk of developing ovarian hyperstimulation syndrome (OHSS) (see Section 4).
Če ste ženska, to zdravljenje povečuje vaše tveganje za razvoj sindroma hiperstimulacije jajčnikov (OHSS) (glejte poglavje 4).
172 GONAL-f should not be administered as a mixture with other medicinal products in the same injection, except for lutropin alfa.
GONALA- f se ne sme dajati v obliki mešanice z drugimi zdravili v isti injekcijski brizgi, razen z lutropinom alfa.
Studies have shown that these two medicines can be mixed and injected together, without either product being adversely affected.
Študije so pokazale, da se ti dve zdravili lahko meša in skupaj injicira, ne da bi to neugodno vplivalo na katero od obeh zdravil.
Pregnancy and breast-feeding
174 Nosečnost in dojenje
For the following cycle, your doctor will prescribe a treatment at a higher starting dose than in the abandoned cycle.
Če vaš zdravnik ne more opaziti odziva po 4 tednih zdravljenja, je treba ta ciklus zdravljenja opustiti. Za naslednji ciklus vam bo vaš zdravnik predpisal zdravljenje z večjim začetnim odmerkom kot v opuščenem ciklusu.